Children with a rare genetic disease lose the cellular structures their brains, muscles and other organs need to produce energy, and many die within their first years of life. Experiments in patients’ cells and mice suggest that activating the energy sensor AMP-activated protein kinase (AMPK) can protect mitochondria that still function and restore energy production – pointing towards the first targeted treatment while overturning the idea that mitochondrial recycling is always beneficial.
